RSC Advances
Page 10 of 12
DOI: 10.1039/C4RA15284K
(m, 1H), 3.14ꢀ3.035 (m, 1H). MS (ESI) m/z 286 (Mꢀ1).
6.85ꢀ6.84 (d, 2H), 5.95 (s, 1H), 4.83 (s, 1H), 3.77 (s,
Anal. Calcd for C10H10BrNO2S: C, 41.68; H, 3.50; N,
4.86. Found: C, 41.51; H, 3.52; N, 4.88.
4.1.12
3H), 3.38ꢀ3.31 (m, 2H), 1.27 (s, 9H). MS (ESI) m/z
338 (Mꢀ1). Anal. Calcd for C16H21NO5S: C, 56.62; H,
6.24; N, 4.13. Found: C, 56.90; H, 6.21; N, 4.17.
4.1.17
(4R)-2-(5-fluoro-2-hydroxyphenyl)thiazolidine-4-
1
carboxylic acid (12) yield 84%. H NMR(300 MHz,
(2R,4R)-3-(tert-butoxycarbonyl)-2-(3-fluorophen
1
DMSOꢀd6) δ 9.89 (b, 0.6H), 7.32ꢀ7.27 (m, 0.4H),
7.16ꢀ7.12 (m, 0.6H), 7.01ꢀ6.87 (m, 1H), 6.84ꢀ6.75 (m,
1H), 5.84 (s, 0.6H), 5.66 (s, 0.4H), 4.22ꢀ4.18 (m,
0.6H), 3.90ꢀ3.85 (m, 0.4H), 3.26ꢀ3.260 (m, 1H),
3.05ꢀ2.98 (m, 1H). MS (ESI) m/z 242 (Mꢀ1). Anal.
Calcd for C10H10FNO3S: C, 49.37; H, 4.14; N, 5.76.
Found: C, 49.56; H, 4.12; N, 5.74.
yl)thiazolidine-4-carboxylic acid (17) yield 77%. H
NMR(300 MHz, DMSOꢀd6) δ 7.64ꢀ7.57 (m, 1H),
7.43ꢀ7.31 (m, 2H), 7.10,ꢀ7.05 (m, 1H), 6.13+5.97 (2s,
1H), 4.72ꢀ4.52 (m, 1H), 3.49ꢀ3.43 (m, 1H), 3.20ꢀ3.03
(m, 1H), 1.35+1.12 (2s, 9H). MS (ESI) m/z 326 (Mꢀ1).
Anal. Calcd for C15H18FNO4S: C, 55.03; H, 5.54; N,
4.28; Found: C, 55.35; H, 5.56; N, 4.26.
General Procedure for the Preparation of TBTCA
derivatives 13-24. A mixture of TCA (1.0 mmol) and
appropriate NaOH (10%, 1.0 mmol) in dioxane (25
mL) was stirred at iceꢀwater temperature for 2 h.
BOC2O (1.0 mmol) was added and stirred at iceꢀwater
temperature for 1 h and then room temperature for 5 h.
Most of Solvent was extracted and appropriate amount
of water was added to adjust to neutral pH values.
Ethyl acetate was added and extracted (50 mL×3), and
washed with appropriate saturated aqueous solution of
common salt, and dried with anhydrous magnesium
sulphate. Solvent was extracted to dry to obtain whiter
solids 13ꢀ24.
4.1.18
(2R,4R)-3-(tert-butoxycarbonyl)-2-(4-fluorophen
yl)thiazolidine-4-carboxylic acid (18) yield 75%. H
1
NMR(300 MHz, CD2Cl2) δ 8.80 (bs, 1H), 7.59 (s, 2H),
7.04 (t, 2H), 5.96 (s, 1H), 4.94 (s, 1H), 3.37 (s, 1H),
1.25 (s, 9H). MS (ESI) m/z 326 (Mꢀ1). Anal. Calcd for
C15H18FNO4S: C, 55.03; H, 5.54; N, 4.28; Found: C,
55.33; H, 5.52; N, 4.30.
4.1.19
(2R,4R)-3-(tert-butoxycarbonyl)-2-(2-chlorophen
yl)thiazolidine-4-carboxylic acid (19) yield 80%. H
1
NMR(300 MHz, CD2Cl2) δ 8.29 (b, 1H), 7.32ꢀ7.29 (m,
2H), 7.22ꢀ7.16 (m, 2H), 6.26 (s, 1H), 4.78ꢀ4.77 (m,
1H), 3.34ꢀ3.33 (m, 2H), 1.21 (s, 9H). MS (ESI) m/z
342 (Mꢀ1). Anal. Calcd for C15H18ClNO4S: C, 52.40;
H, 5.28; N, 4.07; Found: C, 52.40; H, 5.28; N, 4.07.
4.1.20
4.1.13
(2R,4R)-3-(tert-butoxycarbonyl)-2-phenylthiazol
idine-4-carboxylic acid (13) yield 78%. 1H NMR(300
MHz, DMSOꢀd6+CDCl3)
δ 7.56ꢀ7.53 (d, 2H),
7.24ꢀ7.14 (m, 3H), 6.04+5.85 (2s, 1H), 4.75ꢀ4.57 (d,
1H), 3.23ꢀ3.16 (m, 2H), 1.34+1.10 (2s, 9H). MS (ESI)
m/z 308 (Mꢀ1). Anal. Calcd for C15H19NO4S: C, 58.23;
H, 6.19; N, 4.53. Found: C, 58.05; H, 6.15; N, 4.57.
4.1.14
(2R,4R)-3-(tert-butoxycarbonyl)-2-(4-hydroxyph
enyl)thiazolidine-4-carboxylic acid (14) yield 76%.
1H NMR(300 MHz, DMSOꢀd6) δ 9.35 (b, 1H),
7.42ꢀ7.39 (d, 2H), 6.68ꢀ6.65 (d, 2H), 6.01+5.84 (2s,
1H), 4.67ꢀ4.51 (m, 1H), 3.44ꢀ3.37 (m, 1H), 3.15ꢀ3.05
(m, 1H), 1.34+1.12 (2s, 9H). MS (ESI) m/z 324 (Mꢀ1).
Anal. Calcd for C15H19NO5S: C, 55.37; H, 5.89; N,
4.30. Found: C, 55.62; H, 6.85; N, 4.32.
(2R,4R)-3-(tert-butoxycarbonyl)-2-(3-chlorophen
yl)thiazolidine-4-carboxylic acid (20) yield 81%. H
1
NMR(300 MHz, DMSOꢀd6)
δ 13.12 (b, 1H),
7.83ꢀ7.79 (d, 1H), 7.59ꢀ7.57 (d, 1H), 7.39ꢀ7.34 (t, 2H),
6.14+5.98 (2s, 1H), 4.75ꢀ4.56 (m, 1H), 3.52ꢀ3.46 (m,
1H), 3.22ꢀ3.05 (m, 1H), 1.38ꢀ1.14 (2s, 9H). MS (ESI)
m/z 342 (Mꢀ1). Anal. Calcd for C15H18ClNO4S: C,
52.40; H, 5.28; N, 4.07; Found: C, 52.63; H, 5.26; N,
4.09.
4.1.21
(2R,4R)-3-(tert-butoxycarbonyl)-2-(4-chlorophen
1
yl)thiazolidine-4-carboxylic acid (21) yield 73%. H
NMR(300 MHz, DMSOꢀd6)
δ 13.08 (b, 1H),
4.1.15
7.67ꢀ7.64 (d, 2H), 7.39ꢀ7.37 (d, 2H), 6.11+5.96 (2s,
1H), 4.71ꢀ4.56 (m, 1H), 3.49ꢀ3.43 (m, 1H), 3.36 (m,
1H), 3.17ꢀ3.03 (m, 1H),1.34+1.12 (2s, 9H). MS (ESI)
m/z 342 (Mꢀ1). Anal. Calcd for C15H18ClNO4S: C,
52.40; H, 5.28; N, 4.07; Found: C, 52.16; H, 5.30; N,
4.05.
(2R,4R)-3-(tert-butoxycarbonyl)-2-(2-methoxyph
enyl)thiazolidine-4-carboxylic acid (15) yield 84%.
1H NMR(300 MHz, CDCl3+TMS) δ 7.83ꢀ7.60 (m,
1H), 7.277 (m, 1H), 7.26ꢀ7.23 (m, 1H), 6.98ꢀ6.85 (m,
1H), 6.38+6.29 (2s, 1H), 4.84ꢀ4.71 (m, 1H), 3.86 (s,
3H), 3.40ꢀ3.26 (m, 2H), 1.42+1.23 (2s, 9H). MS (ESI)
m/z 338 (Mꢀ1). Anal. Calcd for C16H21NO5S: C, 56.62;
H, 6.24; N, 4.13; Found: C, 56.85; H, 6.22; N, 4.15.
4.1.16
4.1.22
(2R,4R)-2-(2-bromophenyl)-3-(tert-butoxycarbo
nyl)thiazolidine-4-carboxylic acid (22) yield 84%.
1H NMR(300 MHz, DMSOꢀd6) δ 13.19 (b, 0.5H),
8.24ꢀ8.15 (m, 1H), 7.63ꢀ7.56 (m, 1H), 7.40ꢀ7.39 (m,
1H), 7.24ꢀ7.19 (m, 1H), 6.12 (s, 1H), 4.69ꢀ4.52 (m,
1H), 3.54ꢀ3.44 (m, 1H), 3.18ꢀ2.98 (m, 1H), 1.35+1.10
(2R,4R)-3-(tert-butoxycarbonyl)-2-(4-methoxyph
enyl)thiazolidine-4-carboxylic acid (16) yield 80%.
1H NMR(300 MHz, CD2Cl2) δ 7.45ꢀ7.44 (d, 2H),
This journal is © The Royal Society of Chemistry [year]
Journal Name, [year], [vol], 00–00
|
9